There are numerous studies exploring the relationships between SLE and gut microbiota, or between atherosclerosis and gut microbiota, and also between metabolic disorders and both of them
van der Aart-van der Beek AB, Apperloo E, Jongs N, et al
Mazdutide represents another next-generation option
Body measurements including waist, hips, thighs, and arms at consistent points provide direct feedback on composition changes
Second, evaluating L-carnitine as a background therapy in combination with novel anti-fibrotic agents (e.g., GLP-1/GIP dual receptor agonists, FGF21 analogs) to assess its role in consolidating therapeutic efficacy and reducing relapse risk after drug discontinuation
Biochim Biophys Acta 2011